Abstract
Gamma-glutamyl carboxylase (GGCX) plays an important role in blood coagulation through post-translational carboxylation of vitamin K-dependent blood-clotting proteins. This carboxylation process is impaired in the presence of warfarin, a vitamin K antagonist. Recent studies on GGCX have provided insights into association of polymorphisms in this gene, with inter-individual differences in the required warfarin maintenance dose. In order to provide a useful resource for further elucidating this association, we here report a high-resolution single nucleotide polymorphism (SNP) and haplotype maps of an 18-kb genomic region corresponding to the GGCX locus in the Japanese population. Among 41 SNPs, seven insertion/deletion polymorphisms, and a microsatellite polymorphism that we detected by direct sequencing of the DNAs of 96 Japanese individuals who were treated with warfarin, 32 genetic variations have not been reported. Using genotype information from 12 SNPs and the EM algorithm, we estimated haplotypes for this genomic region. Subsequently, we investigated associations of each of these polymorphisms with the warfarin maintenance-dose requirements of 828 Japanese patients, including the 96 patients that were used for DNA sequencing. We found no significant association between the polymorphisms in GGCX and the dose requirement.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Chen LY, Eriksson N, Gwilliam R, Bentley D, Deloukas P, Wadelius M (2005) Gamma-glutamyl carboxylase (GGCX) microsatellite and warfarin dosing. Blood 106(10):3673
Daly AK, King BP (2003) Pharmacogenetics of oral anticoagulants. Pharmacogenetics 13:247–252
Esmon CT, Sadowski JA, Suttie JW (1975) A new carboxylation reaction: The vitan K-dependent incorporation of H14CO3 − into prothrombin. JBC 250(12):4744–4748
FAO/WHO expert consultation on human vitamin and mineral requirements (1998) Chapter 6: Vitamin K. In: Vitamin and mineral requirements in human nutrition, 2nd edn. Report of a joint FAO/WHO expert consultation, Bangkok, Thailand. WHO Library Cataloguing-in-Publication Data, pp 108–129
Furie B, Furie BC (1988) The molecular basis of blood coagulation. Cell 53:505–518
Furie B, Furie BC (1990) Molecular basis of vitamin K-dependent γ-carboxylation. Blood 75:1753–1762
Herman D, Peternel P, Stegnar M, Breskvar K, Dolzan V (2006) The influence of sequence variations in factor VII, γ-glutamyl carboxylase and vitamin K epoxide reductase complex genes on warfarin dose requirement. Thromb Haemost 95:782–787
Horton JD, Bushwick BM (1999) Warfarin therapy: evolving strategies in anticoagulation. Am Fam Physician 59(3):635–646
Kimura R, Miyashita K, Kokubo Y, Akaiwa Y, Otsubo R, Nagatsuka K, Otsuki T, Okayama A, Minematsu K, Naritomi H, Honda S, Tomoike H, Miyata T (2007) Genotypes of vitamin K epoxide reductase, γ-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients. Thrombosis Research 120(2):181–186
Kitamura Y, Moriguchi M, Kaneko H, Morisaki H, Morisaki T, Toyama K, Kamatani N (2002) Determination of probability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithm. Ann Hum Genet 66:183–193
Kuo W-L, Stafford DW, Cruces J, Gray J, Solera J (1995) Chromosomal localization of the gamma-glutamyl carboxylase gene at 2p12. Genomic 25:746–748
Li T, Chang C-Y, Jin D-Y, Lin P-J, Khvorova A, Stafford DW (2004) Identification of the gene for vitamin K epoxide reductase. Nature 427:541–544
Loebstein R, Vecsler M, Kurnik D, Austerweil N, Gak E, Halkin H, Almog S (2005) Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9. Clin Pharmacol Ther 77(5):365–372
Mushiroda T, Ohnishi Y, Saito S, Takahashi A, Kikuchi Y, Saito S, Shimomura H, Wanibuchi Y, Suzuki T, Kamatani N, Nakamura Y (2006) Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients. J Hum Genet 51(3):249–253
Nickerson DA, Tobe VO, Taylor SL (1997) PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 25:2745–2751
Rost S, Fregin A, Ivaskevicius V, Conzelmann E, Hortnagel K, Pelz H-J, Lappegard K, Seifried E, Scharrer I, Tuddenham EGD, Muller CR, Strom TM, Oldenburg J (2004) Mutations in VKORC1 cause warfarin resistance and multiple coagulation fcator deficiency type 2. Nature 427:537–541
Schwartz UI, Stein CM (2006) Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants. Clin Pharmacol Ther 80(1):7–12
Shikata E, Ieiri I, Ishiguro S, Aono H, Inoue K, Koide T, Ohgi S, Otsubo K (2004) Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and γ-glutamyl carboxylase) gene variants with warfarin sensitivity. Blood 103(7):2630–2635
Slatkin M, Excoffier L (1996) Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm. Heredity 76:377–383
Suttie JW (1985) Vitamin K-dependent carboxylase. Ann Rev Biochem 54:459–77
Vecsler M, Loebstein R, Almog S, Kurnik D, Goldman B, Halkin H, Gak E (2006) Combined genetic profiles of components and regulators of the vitamin K-dependent γ-carboxylation system affect individual sensitivity to warfarin. Thromb Haemost 95:205–211
Wadelius M, Chen LY, Downew K, Ghori J, Hunt S, Eriksson N, Wallerman O, Melhus H, Wadelius C, Bentley D, Deloukas P (2005) Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Pharmacogenomics J 5:262–270
Weir BS (1996) Genetic data analysis II: Methods for discrete population genetic data. Sinauer Associates, Inc., Canada
Wu S-M, Cheung W-F, Frazier D, Stafford DW (1991) Cloning and expression of the cDNA for human gamma-glutamyl carboxylase. Science 254:1634–1636
Wu S-M, Stafford DW, Frazier D, Fu Y-Y, High KA, Chu K, Sanchez-Vega B, Solera J (1997) Genomic sequence and transcription start site fot the human γ-glutamyl carboxylase. Blood 89(11):4058–4062
Acknowledgments
We thank all members of the Laboratory for Pharmacogenetics, SRC, RIKEN, Japan, for their helpful contribution to the completion of this study. We also thank Drs Yozo Ohnishi, Aritoshi Iida, Michiaki Kubo, and Susumu Saito for stimulating discussion and helpful comments.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Cha, PC., Mushiroda, T., Takahashi, A. et al. High-resolution SNP and haplotype maps of the human gamma-glutamyl carboxylase gene (GGCX) and association study between polymorphisms in GGCX and the warfarin maintenance dose requirement of the Japanese population. J Hum Genet 52, 856–864 (2007). https://doi.org/10.1007/s10038-007-0183-9
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s10038-007-0183-9
Keywords
This article is cited by
-
Pharmacogenetics of warfarin: challenges and opportunities
Journal of Human Genetics (2013)
-
Single nucleotide polymorphism in ABCG2 is associated with irinotecan-induced severe myelosuppression
Journal of Human Genetics (2009)
